why choose us

First received: October 05, 2026

Clinical Trial: Oral Colloidal Silicon Dioxide Added to Routine Treatment for Acute Urticaria in the Emergency Department

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Urticaria Acute

Study Type: OBSERVATIONAL


Official Title: Early Outcomes With Adjunctive Oral Colloidal Silicon Dioxide for Acute Urticaria in the Emergency Department: A Prospective Observational Pilot Study

Brief Summary: The goal of this observational study is to learn whether adding a single oral dose of colloidal silicon dioxide, an enterosorbent, to routine emergency department treatment is associated with faster early improvement in adults with acute urticaria. The main question it aims to answer is: Is the change in urticaria activity over the first 2 hours different in patients who receive colloidal silicon dioxide in addition to intravenous pheniramine compared with patients who receive intravenous pheniramine alone?…

Read more